FR22M - Nouveau médicament notamment pour le traitement du rhumatisme articulaire aigu ou chronique. - Google Patents

Nouveau médicament notamment pour le traitement du rhumatisme articulaire aigu ou chronique.

Info

Publication number
FR22M
FR22M FR832223A FR832223A FR22M FR 22 M FR22 M FR 22M FR 832223 A FR832223 A FR 832223A FR 832223 A FR832223 A FR 832223A FR 22 M FR22 M FR 22M
Authority
FR
France
Prior art keywords
acute
treatment
new drug
articular rheumatism
chronic articular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR832223A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR793081A external-priority patent/FR1344153A/fr
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Priority to FR832223A priority Critical patent/FR22M/fr
Application granted granted Critical
Publication of FR22M publication Critical patent/FR22M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
FR832223A 1959-04-24 1960-07-06 Nouveau médicament notamment pour le traitement du rhumatisme articulaire aigu ou chronique. Expired FR22M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR832223A FR22M (fr) 1959-04-24 1960-07-06 Nouveau médicament notamment pour le traitement du rhumatisme articulaire aigu ou chronique.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR793081A FR1344153A (fr) 1959-04-24 1959-04-24 Nouveau procédé de préparation de 21-esters de 20-céto-stéroïdes
FR832223A FR22M (fr) 1959-04-24 1960-07-06 Nouveau médicament notamment pour le traitement du rhumatisme articulaire aigu ou chronique.

Publications (1)

Publication Number Publication Date
FR22M true FR22M (fr) 1961-01-06

Family

ID=39811721

Family Applications (1)

Application Number Title Priority Date Filing Date
FR832223A Expired FR22M (fr) 1959-04-24 1960-07-06 Nouveau médicament notamment pour le traitement du rhumatisme articulaire aigu ou chronique.

Country Status (1)

Country Link
FR (1) FR22M (fr)

Similar Documents

Publication Publication Date Title
FR1444M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR1215M (fr) Nouveau médicament, notamment pour le traitement des troubles dus a une hyperestrogénie ou a une hypoandrogénie.
FR362M (fr) Nouveau médicament pour le traitement des infections staphylococciques et des salmonelloses.
BE582173A (fr) Appareil perfectionné pour le traitement des fils.
FR126M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
FR22M (fr) Nouveau médicament notamment pour le traitement du rhumatisme articulaire aigu ou chronique.
FR365M (fr) Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.
FR3066M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
FR1878M (fr) Nouveau polysaccharide, utilisable en thérapeutique, notamment pour le traitement des tumeurs solides.
FR1204M (fr) Nouveau médicament, notamment pour le traitement de l'hyperlipémie chronique ou post-prandiale.
FR385M (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR1172M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR2413M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
BE598672A (fr) Composition thérapeutique pour le traitement des affections hépatiques.
FR2510M (fr) Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues.
FR1456M (fr) Nouveau médicament notamment pour le traitement des carences du corps jaune.
BE630069A (fr) Composition thérapeutique pour le traitement du parkinsonisme.
FR2574M (fr) Nouveau médicament notamment pour le traitement des algies et des manifestations inflammatoires.
FR36M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie postprandiale ou aigue.
BE591743A (fr) Agents thérapeutiques pour le traitement des ulcères peptiques
FR9M (fr) Nouveau médicament notamment pour le traitement des affections rhumatismales articulaires, aigues ou chronique
FR33F (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR31M (fr) Nouveau médicament notamment pour le traitement de l'hypertension artérielle.
FR1039M (fr) Médicament a base de ribonucléase pour le traitement du psoriasis et autres dermatoses.